Two months after Merck announced a billion-dollar-plus deal to buy out late-stage cancer biotech Peloton, some of its staffers are finding new homes.
This is good news for RNA startup Skyhawk Therapeutics, which has nabbed Peloton’s former VP of biology, …
The company is releasing three types of maps meant to help public health organizations stay ahead of disease outbreaks and guide disaster response: population density maps, movement maps and network coverage maps.
The German drugmaker plans to submit its data package for FDA approval by the end of the year, with potential approval next year. The package will include a synthetic control arm comprising real-world data.
Isma Benattia, MBA ’18 
Jane Levy, MBA ‘97 
Patrick Rivelli, SM ‘91 
Rick Ruvkun, MBA ’83 
David Segrera, MBA ’11 
Vin Sharma, MBA ’07 
